1 Beaten-Down Stock That Could Soar by 89%, According to Wall Street

[admin]

Biotech companies, especially small-cap ones, often have explosive growth potential. Let's look at one biotech company Wall Street thinks could skyrocket: bluebird bio (NASDAQ: BLUE). The first is Zynteglo, a treatment for transfusion-dependent beta-thalassemia (TDT), a rare blood disorder.